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Background
Stress CMR myocardial perfusion is a strong risk-strati-
fying tool increasingly used for patient management.
However, the cost-effectiveness of this technique in
patients with suspected ischemia, has never been studied
against nuclear SPECT.
Methods
From 2003-2011, 707 patients underwent CMR-MPI for
ischemia assessment in our center. Estimated pre-test
cardiac risk derived from a combined Framingham
Heart Study and Diamond Forrester risk percentage was
used to match CMR patients against 39,876 patients
who underwent pharmacologic stress SPECT in another
tertiary-care center during the same time period. Fra-
mingham scoring system for the prediction of cardiovas-
cular risk was also stratified by presence or absence of
prior evidence of CAD. A validated computer algorithm
was used to perform 1:1 patient risk-matching. For all
patients, cardiac events (acute MI/death), angiographi-
cally-significant CAD, percutaneous coronary interven-
tion and bypass grafting, repeat stress testing/imaging
within 2 years, and cost estimates for these events from
national average were collected for cost-effectiveness
analysis.
Results
One-to-one risk-profile matching between CMR-MPI
and SPECT was successful in 704 patients (99.6%).
Ischemia by SPECT was positive, negative, and equivocal
in 8%, 74%, and 18%, which compared with 22%, 75%,
and 3%, respectively by CMR-MPI. A negative SPECT
was associated with a 2-year cardiac event rate of 4.6%
compared to 1.3% by CMR-MPI (p=0.002). Other items
relevant to cost-effectiveness analysis using imaging for
“gate-keeping” stratification are shown in Table 1.
Conclusions
In patients with an intermediate risk of ischemic heart
disease, stress CMR myocardial perfusion is cost-effec-
tive when compared to pharmacologic stress SPECT. A
negative stress CMR perfusion study is associated with a
lower 2 year event rate and lower downstream costs.
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CMR-MPI Negative or equivocal for
Ischemia
SPECT Negative or equivocal for
Ischemia
Cardiac Event Rate (%/2 years) N=9 (1.3%) N=32 (4.6%)
Need for Repeat Imaging within 2 years N=27 (6%) N=99 (14%)
Need for coronary angiography within 2 years N=24 (3%) N=155 (22%)
PCI or Bypass Surgery Performed within 2 years N=15 N=46
Estimated Cost of SPECT or CMR-MPI (N=705) $704,000 $598,400
Estimated Costs of Related Patient Care over 2-yrs
($)
$789,642 $3,419,355
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